JP2018512431A5 - - Google Patents

Download PDF

Info

Publication number
JP2018512431A5
JP2018512431A5 JP2017553132A JP2017553132A JP2018512431A5 JP 2018512431 A5 JP2018512431 A5 JP 2018512431A5 JP 2017553132 A JP2017553132 A JP 2017553132A JP 2017553132 A JP2017553132 A JP 2017553132A JP 2018512431 A5 JP2018512431 A5 JP 2018512431A5
Authority
JP
Japan
Prior art keywords
less
units
unit
parent
antibody species
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017553132A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018512431A (ja
JP6962819B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/026620 external-priority patent/WO2016164708A1/en
Publication of JP2018512431A publication Critical patent/JP2018512431A/ja
Publication of JP2018512431A5 publication Critical patent/JP2018512431A5/ja
Application granted granted Critical
Publication of JP6962819B2 publication Critical patent/JP6962819B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017553132A 2015-04-10 2016-04-08 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法 Active JP6962819B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562146116P 2015-04-10 2015-04-10
US62/146,116 2015-04-10
US201562249180P 2015-10-30 2015-10-30
US62/249,180 2015-10-30
PCT/US2016/026620 WO2016164708A1 (en) 2015-04-10 2016-04-08 Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020080220A Division JP7111767B2 (ja) 2015-04-10 2020-04-30 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法

Publications (3)

Publication Number Publication Date
JP2018512431A JP2018512431A (ja) 2018-05-17
JP2018512431A5 true JP2018512431A5 (enExample) 2019-05-09
JP6962819B2 JP6962819B2 (ja) 2021-11-05

Family

ID=57072068

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017553132A Active JP6962819B2 (ja) 2015-04-10 2016-04-08 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法
JP2020080220A Active JP7111767B2 (ja) 2015-04-10 2020-04-30 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法
JP2021085111A Pending JP2021119207A (ja) 2015-04-10 2021-05-20 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020080220A Active JP7111767B2 (ja) 2015-04-10 2020-04-30 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法
JP2021085111A Pending JP2021119207A (ja) 2015-04-10 2021-05-20 親ホモ二量体抗体種からのヘテロ二量体多重特異性抗体の精製方法

Country Status (6)

Country Link
US (2) US10787500B2 (enExample)
EP (1) EP3280444B1 (enExample)
JP (3) JP6962819B2 (enExample)
CN (1) CN108472360B (enExample)
AU (2) AU2016245887B2 (enExample)
WO (1) WO2016164708A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4793360A2 (en) 2006-03-31 2026-08-19 Chugai Seiyaku Kabushiki Kaisha Methods for controlling blood pharmacokinetics of antibodies
EP3127921A1 (en) 2007-09-26 2017-02-08 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substition in cdr
EP4050026A1 (en) * 2014-04-01 2022-08-31 Adimab, LLC Method of obtaining or identifying one or more common light chains for use in preparing a multispecific antibody
TWI700300B (zh) 2014-09-26 2020-08-01 日商中外製藥股份有限公司 中和具有第ｖｉｉｉ凝血因子（ｆｖｉｉｉ）機能替代活性的物質之抗體
JP7082484B2 (ja) 2015-04-01 2022-06-08 中外製薬株式会社 ポリペプチド異種多量体の製造方法
EP3280444B1 (en) 2015-04-10 2024-05-08 Adimab, LLC Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species
US20200270363A1 (en) 2015-12-25 2020-08-27 Chugai Seiyaku Kabushiki Kaisha Antibody having enhanced activity, and method for modifying same
SG11201803989WA (en) 2015-12-28 2018-06-28 Chugai Pharmaceutical Co Ltd Method for promoting efficiency of purification of fc region-containing polypeptide
AU2017255077B2 (en) 2016-04-28 2024-05-16 Chugai Seiyaku Kabushiki Kaisha Antibody-containing preparation
CA3027018A1 (en) 2016-07-29 2018-02-01 Chugai Seiyaku Kabushiki Kaisha Bispecific antibody exhibiting increased alternative fviii-cofactor-function activity
US11352438B2 (en) 2016-09-06 2022-06-07 Chugai Seiyaku Kabushiki Kaisha Methods of using a bispecific antibody that recognizes coagulation factor IX and/or activated coagulation factor IX and coagulation factor X and/or activated coagulation factor X
JP7209298B2 (ja) 2017-03-31 2023-01-20 公立大学法人奈良県立医科大学 血液凝固第ｖｉｉｉ因子の機能を代替する多重特異性抗原結合分子を含有する、血液凝固第ｉｘ因子異常症の予防および／または治療に用いられる医薬組成物
CA3071236A1 (en) 2017-09-29 2019-04-04 Chugai Seiyaku Kabushiki Kaisha Multispecific antigen-binding molecule having blood coagulation factor viii (fviii) cofactor function-substituting activity, and pharmaceutical formulation containing said moleculeas active ingredient
KR20260090008A (ko) * 2017-11-01 2026-06-16 추가이 세이야쿠 가부시키가이샤 생물 활성이 저하된 항체 배리언트 및 아이소폼
SG11202101369XA (en) * 2018-08-17 2021-03-30 Regeneron Pharma Method and chromatography system for determining amount and purity of a multimeric protein
SG11202102713TA (en) * 2018-09-21 2021-04-29 Teneobio Inc Methods for purifying heterodimeric, multispecific antibodies
US11022585B2 (en) 2019-06-09 2021-06-01 Dionex Corporation Methods and systems for optimizing buffer conditions with liquid chromatography
CN114539416B (zh) * 2020-11-26 2024-11-08 盛禾(中国)生物制药有限公司 一种双特异性抗体的层析纯化工艺

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US231A (en) 1837-06-10 Stove for heating irons for the use of tailors
US459004A (en) 1891-09-08 Box for steaming cops
US8188A (en) 1851-07-01 Htkstaht
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
US6291158B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for tapping the immunological repertoire
US6291159B1 (en) 1989-05-16 2001-09-18 Scripps Research Institute Method for producing polymers having a preselected activity
CA2079802C (en) 1990-04-05 2001-09-18 Roberto Crea Walk-through mutagenesis
US5665563A (en) 1991-10-11 1997-09-09 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
EP0566714B1 (en) 1991-10-11 1997-01-02 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
US5492817A (en) 1993-11-09 1996-02-20 Promega Corporation Coupled transcription and translation in eukaryotic cell-free extract
US20030036092A1 (en) 1991-11-15 2003-02-20 Board Of Regents, The University Of Texas System Directed evolution of enzymes and antibodies
US5866344A (en) 1991-11-15 1999-02-02 Board Of Regents, The University Of Texas System Antibody selection methods using cell surface expressed libraries
US5667988A (en) 1992-01-27 1997-09-16 The Scripps Research Institute Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
US5731168A (en) 1995-03-01 1998-03-24 Genentech, Inc. Method for making heteromultimeric polypeptides
US6828422B1 (en) 1995-08-18 2004-12-07 Morphosys Ag Protein/(poly)peptide libraries
EP0859841B1 (en) 1995-08-18 2002-06-19 MorphoSys AG Protein/(poly)peptide libraries
US6165718A (en) 1996-01-10 2000-12-26 Novo Nordisk A/S Novo Alle Method for in vivo production of a mutant library in cells
IL131016A (en) 1997-01-21 2004-12-15 Gen Hospital Corp Selection of proteins using RNA-protein blends
US6261804B1 (en) 1997-01-21 2001-07-17 The General Hospital Corporation Selection of proteins using RNA-protein fusions
JP4093507B2 (ja) * 1997-03-10 2008-06-04 旭化成ファーマ株式会社 緩衝液組成
US6159688A (en) 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
DE69834032T2 (de) 1997-04-23 2006-12-07 Universität Zürich Verfahren zur erkennung von nucleinsäuremolekülen codierend für (poly)peptide, welche mit zielmolekülen interagieren
US7951917B1 (en) 1997-05-02 2011-05-31 Genentech, Inc. Method for making multispecific antibodies having heteromultimeric and common components
JP4860098B2 (ja) 2000-12-18 2012-01-25 ダイアックス、コープ 遺伝的パッケージの焦点を合わせたライブラリー
US20060235208A1 (en) 2002-09-27 2006-10-19 Xencor, Inc. Fc variants with optimized properties
US20060134105A1 (en) 2004-10-21 2006-06-22 Xencor, Inc. IgG immunoglobulin variants with optimized effector function
EP1786918A4 (en) 2004-07-17 2009-02-11 Imclone Systems Inc NEW BISPECIFIC ANTIBODY TETRAVALENT
EP2824183B1 (en) * 2005-04-08 2020-07-29 Chugai Seiyaku Kabushiki Kaisha Methods for producing bispecific antibodies
CN101460622A (zh) * 2006-03-31 2009-06-17 中外制药株式会社 用于纯化双特异性抗体的抗体修饰方法
JP5144499B2 (ja) * 2006-03-31 2013-02-13 中外製薬株式会社 二重特異性抗体を精製するための抗体改変方法
WO2008075455A1 (ja) 2006-12-21 2008-06-26 Sekisui Medical Co., Ltd. トロンビン含有溶液中のα－トロンビンの安定化方法
CA2693053C (en) 2007-05-30 2021-01-05 Xencor, Inc. Methods and compositions for inhibiting cd32b expressing cells
CA2697922A1 (en) 2007-08-28 2009-03-12 Biogen Idec Ma Inc. Compositions that bind multiple epitopes of igf-1r
WO2009036379A2 (en) 2007-09-14 2009-03-19 Adimab, Inc. Rationally designed, synthetic antibody libraries and uses therefor
US8877688B2 (en) 2007-09-14 2014-11-04 Adimab, Llc Rationally designed, synthetic antibody libraries and uses therefor
EP3127921A1 (en) * 2007-09-26 2017-02-08 Chugai Seiyaku Kabushiki Kaisha Method of modifying isoelectric point of antibody via amino acid substition in cdr
EP3663318A1 (en) 2008-01-07 2020-06-10 Amgen Inc. Method for making antibody fc-heterodimeric molecules using electrostatic steering effects
KR101181106B1 (ko) 2008-03-06 2012-09-07 샤프 가부시키가이샤 액티브?매트릭스형 표시장치
EP2297209A4 (en) 2008-06-03 2012-08-01 Abbott Lab IMMUNOGLOBULINS WITH TWO VARIABLE DOMAINS AND USES THEREOF
JP5540095B2 (ja) * 2009-07-24 2014-07-02 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 抗体製造の最適化
US9493578B2 (en) 2009-09-02 2016-11-15 Xencor, Inc. Compositions and methods for simultaneous bivalent and monovalent co-engagement of antigens
CA2781682A1 (en) 2009-12-04 2011-06-09 Genentech, Inc. Multispecific antibodies, antibody analogs, compositions, and methods
WO2011133886A2 (en) * 2010-04-23 2011-10-27 Genentech, Inc. Production of heteromultimeric proteins
MX381912B (es) 2010-07-16 2025-03-13 Adimab Llc Colecciones de anticuerpos.
BR112013002334A2 (pt) 2010-07-30 2016-05-24 Medimmune Llc método para purificar polipeptídeos ou imunoconjugados ativos.
IN2014CN03887A (enExample) * 2011-10-27 2015-10-16 Genmab As
EP3517548A1 (en) 2012-03-13 2019-07-31 NovImmune S.A. Readily isolated bispecific antibodies with native immunoglobulin format
JP2015537212A (ja) * 2012-11-15 2015-12-24 ジェネンテック， インコーポレイテッド イオン強度媒介のｐｈ勾配イオン交換クロマトグラフィー
EP3280444B1 (en) 2015-04-10 2024-05-08 Adimab, LLC Methods for purifying heterodimeric multispecific antibodies from parental homodimeric antibody species

Similar Documents

Publication Publication Date Title
Gomis‐Fons et al. Model‐based design and control of a small‐scale integrated continuous end‐to‐end mAb platform
Westermeier Reiner Westermeier, Tom Naven, and Hans-Rudolf Hçpker Proteomics in Practice
Hammerschmidt et al. Continuous precipitation of IgG from CHO cell culture supernatant in a tubular reactor
Hou et al. Advective hydrogel membrane chromatography for monoclonal antibody purification in bioprocessing
Westermeier et al. Proteomics in practice: a guide to successful experimental design
Stein et al. Cation exchange chromatography in antibody purification: pH screening for optimised binding and HCP removal
Nfor et al. Multi‐dimensional fractionation and characterization of crude protein mixtures: toward establishment of a database of protein purification process development parameters
Buyel et al. Generic chromatography‐based purification strategies accelerate the development of downstream processes for biopharmaceutical proteins produced in plants
ES3053015T3 (en) Chromatography
JP2015537212A5 (enExample)
JP2018516229A5 (enExample)
Heiss et al. Identification and deletion of the major secreted protein of Pichia pastoris
IL297116A (en) A method for purifying single-stranded RNA
CA2888824A1 (en) Elution of biomolecules from multi-modal resins using mes as mobile phase modifier
Zhou et al. Large‐scale identification of human biliary proteins from a cholesterol stone patient using a proteomic approach
Connell‐Crowley et al. Cation exchange chromatography provides effective retrovirus clearance for antibody purification processes
Pirrung et al. Model-based optimization of integrated purification sequences for biopharmaceuticals
CN104136121A (zh) 减少离子交换色谱中的pH漂移
Chen et al. Partition coefficient screening–An effective approach for finding the best conditions for byproduct removal as demonstrated by a bispecific antibody purification case
Pasquier et al. Assessment of membrane‐based downstream purification processes as a replacement to traditional resin bead for monoclonal antibody purification
Morrow Jr Advances in antibody manufacturing using mammalian cells
CN106480014B (zh) 选择性分离核酸的方法及其套组
Jandera Comparison of various modes and phase systems for analytical HPLC
Moosmann et al. Purification of PEGylated proteins, with the example of PEGylated lysozyme and PEGylated scFv
KR102140531B1 (ko) Gly-Tβ4의 제조방법